Matthias G Wacker

A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release.

Volker Albrecht, Shakti Nagpal, Svenja Braner, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Dealing with nanosafety around the globe-Regulation vs. innovation.

Ana Proykova, Matthias G Wacker, M. Wacker, 2016, International journal of pharmaceutics.

Nanotherapeutics--product development along the "nanomaterial" discussion.

Matthias G Wacker, M. Wacker, 2014, Journal of pharmaceutical sciences.